Cargando…

Temporal Validation of the UKPDS Outcomes Model Using 10-Year Posttrial Monitoring Data

OBJECTIVE: To evaluate the accuracy of the UK Prospective Diabetes Study Outcomes Model (UKPDS-OM) in predicting clinical outcomes during the UKPDS posttrial monitoring (PTM) period. RESEARCH DESIGN AND METHODS: At trial end in 1997, the 4,031 surviving UKPDS patients, of the 5,102 originally enroll...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leal, Jose, Hayes, Alison J., Gray, Alastair M., Holman, Rury R., Clarke, Philip M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661828/ https://www.ncbi.nlm.nih.gov/pubmed/23275370 http://dx.doi.org/10.2337/dc12-1120

Ejemplares similares

Historical HbA(1c) Values May Explain the Type 2 Diabetes Legacy Effect: UKPDS 88
por: Lind, Marcus, et al.
Publicado: (2021)

The effect of diabetes complications on health-related quality of life: estimating the bias due to unobserved heterogeneity using the UKPDS
por: Alva, Maria L, et al.
Publicado: (2011)

Validation of the UKPDS 82 risk equations within the Cardiff Diabetes Model
por: McEwan, Philip, et al.
Publicado: (2015)

Posttrial Access to Medical Interventions: Intricacies, Challenges, and Solutions
por: Singh, Harmanjit, et al.
Publicado: (2019)

Accurately Reflecting Uncertainty When Using Patient-Level Simulation Models to Extrapolate Clinical Trial Data
por: Dakin, Helen A., et al.
Publicado: (2020)

Continued Posttrial Benefits of Buprenorphine Extended Release: RECOVER Study Findings
por: Boyett, Brent, et al.
Publicado: (2023)

Therapeutic Targets for Type 2 Diabetes Post-UKPDS
por: Yudkin, John S
Publicado: (2000)

External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes
por: van Dieren, S., et al.
Publicado: (2010)

Cardiovascular Risk Estimated by UKPDS Risk Engine Algorithm in Diabetes
por: Kavaric, Nebojsa, et al.
Publicado: (2018)

Effects of Posttrial Antihypertensive Drugs on Morbidity and Mortality: Findings from 15-Year Passive Follow-Up after ALLHAT Ended
por: Du, Xianglin L., et al.
Publicado: (2021)

Estimating Systolic Blood Pressure Intervention Trial Participant Posttrial Survival Using Pooled Epidemiologic Cohort Data
por: Bellows, Brandon K., et al.
Publicado: (2021)

Health utilities in Chinese patients with coronary heart disease and impaired glucose tolerance (ACE): A longitudinal analysis of a randomized, double‐blind, placebo‐controlled trial
por: Leal, José, et al.
Publicado: (2022)

Predicting Changes in Cardiovascular Risk Factors in Type 2 Diabetes in the Post-UKPDS Era: Longitudinal Analysis of the Swedish National Diabetes Register
por: Ahmad Kiadaliri, Aliasghar, et al.
Publicado: (2013)

Estimation of the Long-term Cardiovascular Events Using UKPDS Risk Engine in Metabolic Syndrome Patients
por: Shivakumar, V., et al.
Publicado: (2014)

Potential modification of the UKPDS risk engine and evaluation of macrovascular event rates in controlled clinical trials
por: Yang, Fred, et al.
Publicado: (2013)

Economic Evaluation of Factorial Trials: Cost-Utility Analysis of the Atorvastatin in Factorial With Omega EE90 Risk Reduction in Diabetes 2 × 2 × 2 Factorial Trial of Atorvastatin, Omega-3 Fish Oil, and Action Planning
por: Dakin, Helen A., et al.
Publicado: (2020)

Group Telegaming Through Immersive Virtual Reality to Improve Mental Health Among Adolescents With Physical Disabilities: Pre- and Posttrial Protocol
por: Lai, Byron, et al.
Publicado: (2022)

Prediction of Coronary Heart Disease Risk in a General, Pre-Diabetic, and Diabetic Population During 10 Years of Follow-up: Accuracy of the Framingham, SCORE, and UKPDS Risk Functions: The Hoorn Study
por: van der Heijden, Amber A.W.A., et al.
Publicado: (2009)

Benchmarking the Cost-Effectiveness of Interventions Delaying Diabetes: A Simulation Study Based on NAVIGATOR Data
por: Leal, Jose, et al.
Publicado: (2020)

Evaluating the impact of type 2 diabetes mellitus on cardiovascular risk in persons with metabolic syndrome using the UKPDS risk engine
por: Ogedengbe, O Stephen, et al.
Publicado: (2015)

Estimated incidence of cardiovascular complications related to type 2 diabetes in Mexico using the UKPDS outcome model and a population-based survey
por: Reynoso-Noverón, Nancy, et al.
Publicado: (2011)

Cardiovascular Risk Assessment with Vascular Function, Carotid Atherosclerosis and the UKPDS Risk Engine in Korean Patients with Newly Diagnosed Type 2 Diabetes
por: Seon, Choon Sik, et al.
Publicado: (2011)

Lifetime cost-effectiveness simulation of once-weekly exenatide in type 2 diabetes: A cost-utility analysis based on the EXSCEL trial
por: Becker, Frauke, et al.
Publicado: (2022)

Survival, Dependency, and Health-Related Quality of Life in Patients With Ruptured Intracranial Aneurysm: 10-Year Follow-up of the United Kingdom Cohort of the International Subarachnoid Aneurysm Trial
por: Hua, Xinyang, et al.
Publicado: (2020)

Survival, Dependency, and Health-Related Quality of Life in Patients With Ruptured Intracranial Aneurysm: 10-Year Follow-up of the United Kingdom Cohort of the International Subarachnoid Aneurysm Trial
por: Hua, Xinyang, et al.
Publicado: (2021)

Comparison of the Framingham Risk Score, UKPDS Risk Engine, and SCORE for Predicting Carotid Atherosclerosis and Peripheral Arterial Disease in Korean Type 2 Diabetic Patients
por: Ahn, Hye-Ran, et al.
Publicado: (2011)

Sand dam contributions to year-round water security monitored through telemetered handpump data
por: Ritchie, Hannah, et al.
Publicado: (2023)

Lanthanum carbonate: safety data after 10 years
por: Hutchison, Alastair J, et al.
Publicado: (2016)

Prediction and validation of exenatide risk marker effects on progression of renal disease: Insights from EXSCEL
por: Idzerda, Nienke M. A., et al.
Publicado: (2020)

The impact of individualised cardiovascular disease (CVD) risk estimates and lifestyle advice on physical activity in individuals at high risk of CVD: a pilot 2 × 2 factorial understanding risk trial
por: Price, Hermione C, et al.
Publicado: (2008)

A Meta-Analysis of the Relative Risk of Mortality for Type 1 Diabetes Patients Compared to the General Population: Exploring Temporal Changes in Relative Mortality
por: Lung, Tom W. C., et al.
Publicado: (2014)

Metagenomic Predictions: A Review 10 years on
por: Ross, Elizabeth M, et al.
Publicado: (2022)

Hemodynamic monitoring over the past 10 years
por: Pinsky, Michael R
Publicado: (2006)

Initiating Insulin as Part of the Treating To Target in Type 2 Diabetes (4-T) Trial: An interview study of patients' and health professionals' experiences
por: Jenkins, Nicholas, et al.
Publicado: (2010)

Cost-effectiveness of bilateral vs. single internal thoracic artery grafts at 10 years
por: Little, Matthew, et al.
Publicado: (2021)

Effect of race on cardiometabolic responses to once-weekly exenatide: insights from the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)
por: Davis, Timothy M. E., et al.
Publicado: (2022)

Risk prediction models for incident type 2 diabetes in Chinese people with intermediate hyperglycemia: a systematic literature review and external validation study
por: Xu, Shishi, et al.
Publicado: (2022)

Health selection into neighborhoods among patients enrolled in a clinical trial
por: Arcaya, Mariana C., et al.
Publicado: (2017)

Development and validation of a model to predict cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke in patients with type 2 diabetes mellitus and established atherosclerotic cardiovascular disease
por: Stevens, Susanna R., et al.
Publicado: (2022)

Meta-analysis of the impact of alpha-glucosidase inhibitors on incident diabetes and cardiovascular outcomes
por: Coleman, Ruth L., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_oql0etc3nfbnuu05gikbho6bn4